UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2019
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-38718
Federal Life Group, Inc.
(Exact name of registrant as specified in its charter)
Pennsylvania |
|
82-4944172 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
3750 West Deerfield Road
Riverwoods, Illinois 60015
(Address of principal executive offices, including zip code)
(847) 520-1900
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common stock, par value $.01 |
FLFG |
OTC Pink Open Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☒ |
Emerging growth company |
|
☒ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
APPLICABLE TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
As of May 20, 2019, there were 3,530,250 shares of the registrant’s common stock, $.01 par value, outstanding.
|
|
|
|
1 |
|
|
1 |
|
|
1 |
|
CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) |
|
2 |
|
3 |
|
|
4 |
|
|
5 |
|
|
5 |
|
|
6 |
|
|
6 |
|
|
8 |
|
|
11 |
|
|
11 |
|
|
15 |
|
|
15 |
|
|
16 |
|
|
16 |
|
|
16 |
|
|
17 |
|
|
17 |
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
18 |
|
25 |
|
|
|
|
|
27 |
|
|
27 |
|
|
27 |
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
|
27 |
|
27 |
|
|
27 |
|
|
27 |
|
|
28 |
|
|
|
|
|
29 |
PART I – FINANCIAL INFORMATION
FEDERAL LIFE GROUP, INC.
(Dollars in thousands)
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||
|
|
(unaudited) |
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
Fixed maturity securities available for sale, at fair value (amortized cost: 2019, $192,573; 2018, $187,035) |
|
$ |
195,753 |
|
|
$ |
184,475 |
|
Equity securities, at fair value |
|
|
3,806 |
|
|
|
6,004 |
|
Policy loans |
|
|
9,488 |
|
|
|
9,581 |
|
Other invested assets |
|
|
536 |
|
|
|
202 |
|
Total investments |
|
|
209,583 |
|
|
|
200,262 |
|
Cash and cash equivalents |
|
|
29,842 |
|
|
|
33,252 |
|
Real estate, property and equipment, net |
|
|
2,093 |
|
|
|
2,130 |
|
Accrued investment income |
|
|
2,069 |
|
|
|
1,908 |
|
Accounts receivable |
|
|
527 |
|
|
|
498 |
|
Reinsurance recoverables |
|
|
3,521 |
|
|
|
3,556 |
|
Prepaid reinsurance premiums |
|
|
1,467 |
|
|
|
1,418 |
|
Deferred policy acquisition costs, net |
|
|
12,832 |
|
|
|
13,533 |
|
Deferred sales inducement costs, net |
|
|
1,415 |
|
|
|
1,348 |
|
Deferred tax asset, net |
|
|
– |
|
|
|
492 |
|
Other assets |
|
|
608 |
|
|
|
511 |
|
Separate account asset |
|
|
22,922 |
|
|
|
20,819 |
|
Total Assets |
|
$ |
286,879 |
|
|
$ |
279,727 |
|
Liabilities |
|
|
|
|
|
|
|
|
Policy liabilities and accruals: |
|
|
|
|
|
|
|
|
Policyholder account balance |
|
$ |
117,995 |
|
|
$ |
116,298 |
|
Future life policy benefits |
|
|
71,444 |
|
|
|
71,992 |
|
Future accident and health policy benefits |
|
|
355 |
|
|
|
345 |
|
Reserve for deposit type contracts |
|
|
10,504 |
|
|
|
10,587 |
|
Other policyholder funds |
|
|
998 |
|
|
|
1,398 |
|
Unearned revenue |
|
|
1,342 |
|
|
|
1,367 |
|
Deferred reinsurance settlements |
|
|
2,563 |
|
|
|
2,641 |
|
Deferred tax liability, net |
|
|
79 |
|
|
|
– |
|
Other liabilities |
|
|
1,513 |
|
|
|
1,360 |
|
Separate account liability |
|
|
22,922 |
|
|
|
20,819 |
|
Total Liabilities |
|
|
229,715 |
|
|
|
226,807 |
|
Equity |
|
|
|
|
|
|
|
|
Common stock, par value $.01 per share, 4,010,250 shares authorized; issued and outstanding: |
|
|
|
|
|
|
|
|
2019 - 3,530,250 |
|
|
|
|
|
|
|
|
2018 - 3,530,150 |
|
|
35 |
|
|
|
35 |
|
Additional paid-in capital |
|
|
33,110 |
|
|
|
33,076 |
|
Retained earnings |
|
|
22,796 |
|
|
|
21,774 |
|
Accumulated other comprehensive income (loss) |
|
|
1,223 |
|
|
|
(1,965 |
) |
Total Equity |
|
|
57,164 |
|
|
|
52,920 |
|
Total Liabilities and Equity |
|
$ |
286,879 |
|
|
$ |
279,727 |
|
See accompanying notes to unaudited consolidated financial statements
1
CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Dollars in thousands, except share and per share data)
(Unaudited)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Revenues |
|
|
|
|
|
|
|
|
Insurance revenues |
|
$ |
2,120 |
|
|
$ |
2,744 |
|
Net investment income |
|
|
2,201 |
|
|
|
2,107 |
|
Net investment gains |
|
|
574 |
|
|
|
90 |
|
Other revenues |
|
|
26 |
|
|
|
49 |
|
Total Revenues |
|
|
4,921 |
|
|
|
4,990 |
|
Benefits and expenses |
|
|
|
|
|
|
|
|
Policyholder benefits |
|
|
1,954 |
|
|
|
3,095 |
|
Interest credit to policyholders |
|
|
70 |
|
|
|
(48 |
) |
Operating costs and expenses |
|
|
2,459 |
|
|
|
2,241 |
|
Amortization of deferred acquisition and sales inducement costs |
|
|
371 |
|
|
|
374 |
|
Taxes, licenses and fees |
|
|
189 |
|
|
|
197 |
|
Dividends to policyholders |
|
|
18 |
|
|
|
18 |
|
Total Benefits and Expenses |
|
|
5,061 |
|
|
|
5,877 |
|
Net loss before taxes |
|
|
(140 |
) |
|
|
(887 |
) |
Tax expense (benefit) |
|
|
(2 |
) |
|
|
3 |
|
Net loss |
|
$ |
(138 |
) |
|
$ |
(890 |
) |
Other Comprehensive Income (Loss), net of tax: |
|
|
|
|
|
|
|
|
Unrealized holding gains (losses) arising during the period (net of tax) |
|
|
4,997 |
|
|
|
(4,847 |
) |
Adjustment to deferred acquisition costs (net of tax) |
|
|
(649 |
) |
|
|
582 |
|
Other Comprehensive Income (Loss) |
|
|
4,348 |
|
|
|
(4,265 |
) |
Comprehensive Gain (Loss) |
|
$ |
4,210 |
|
|
$ |
(5,155 |
) |
Earnings per common share for the periods (Note 12): |
|
Three months ended March 31, |
|
|
Pro forma for the three months ended March 31, |
|
||
|
|
2019 |
|
|
2018 |
|
||
Basic loss per common share |
|
$ |
(0.04 |
) |
|
$ |
(0.25 |
) |
Diluted loss per common share |
|
$ |
(0.04 |
) |
|
$ |
(0.25 |
) |
See accompanying notes to unaudited consolidated financial statements
2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
(Dollars in thousands, except share and per share data)
(Unaudited)
|
|
Common Stock |
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
||||||
|
|
Shares |
|
|
Amount |
|
|
Additional Paid-In Capital |
|
|
Other Comprehensive Income (Loss) |
|
|
Retained Earnings |
|
|
Total Stockholders' Equity |
|
||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||
Balance, December 31, 2017 |
|
|
– |
|
|
$ |
– |
|
|
$ |
– |
|
|
$ |
4,757 |
|
|
$ |
26,600 |
|
|
$ |
31,357 |
|
Net loss for the period |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(890 |
) |
|
|
(890 |
) |
Other comprehensive loss |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(4,265 |
) |
|
|
– |
|
|
|
(4,265 |
) |
Balance, March 31, 2018 |
|
|
– |
|
|
$ |
– |
|
|
$ |
– |
|
|
$ |
492 |
|
|
$ |
25,710 |
|
|
$ |
26,202 |
|
Balance, December 31, 2018 |
|
|
3,530,150 |
|
|
$ |
35 |
|
|
$ |
33,076 |
|
|
$ |
(1,965 |
) |
|
$ |
21,774 |
|
|
$ |
52,920 |
|
Net loss for the period |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(138 |
) |
|
|
(138 |
) |
Paid in capital |
|
|
100 |
|
|
|
– |
|
|
|
34 |
|
|
|
– |
|
|
|
– |
|
|
|
34 |
|
Cumulative net effect of adoption of new accounting principle |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
(1,160 |
) |
|
|
1,160 |
|
|
|
– |
|
Other comprehensive income |
|
|
– |
|
|
|
– |
|
|
|
– |
|
|
|
4,348 |
|
|
|
– |
|
|
|
4,348 |
|
Balance, March 31, 2019 |
|
|
3,530,250 |
|
|
$ |
35 |
|
|
$ |
33,110 |
|
|
$ |
1,223 |
|
|
$ |
22,796 |
|
|
$ |
57,164 |
|
See accompanying notes to unaudited consolidated financial statements
3
CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
|
|
Three Months Ended March 31, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(138 |
) |
|
$ |
(890 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Investment gains, net |
|
|
(574 |
) |
|
|
(90 |
) |
Amortization on investments |
|
|
(11 |
) |
|
|
(21 |
) |
Depreciation |
|
|
47 |
|
|
|
68 |
|
Stock-based compensation |
|
|
145 |
|
|
|
– |
|
Deferred insurance acquisition costs |
|
|
(482 |
) |
|
|
(506 |
) |
Deferred sales inducement costs |
|
|
(76 |
) |
|
|
(99 |
) |
Interest and amortization of deferred acquisition and sales inducement costs |
|
|
371 |
|
|
|
374 |
|
Change in value of derivatives and other |
|
|
(314 |
) |
|
|
101 |
|
Change in accrued investment income |
|
|
(162 |
) |
|
|
(25 |
) |
Change in receivables |
|
|
(29 |
) |
|
|
(654 |
) |
Change in reinsurance recoverable |
|
|
35 |
|
|
|
75 |
|
Change in prepaid reinsurance premiums |
|
|
(49 |
) |
|
|
(46 |
) |
Change in policy benefits |
|
|
(937 |
) |
|
|
(146 |
) |
Change in unearned revenue |
|
|
(25 |
) |
|
|
(36 |
) |
Change in deferred reinsurance settlements |
|
|
(77 |
) |
|
|
(75 |
) |
Change in other |
|
|
(57 |
) |
|
|
45 |
|
Net cash used in operating activities |
|
|
(2,333 |
) |
|
|
(1,925 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Proceeds from investments sold or matured: |
|
|
|
|
|
|
|
|
Fixed maturity securities |
|
|
3,768 |
|
|
|
5,614 |
|
Equity securities |
|
|
2,827 |
|
|
|
– |
|
Derivatives |
|
|
77 |
|
|
|
128 |
|
Policy loans |
|
|
94 |
|
|
|
102 |
|
Costs of investments purchased: |
|
|
|
|
|
|
|
|
Fixed maturity securities |
|
|
(9,286 |
) |
|
|
(6,093 |
) |
Equity securities |
|
|
(35 |
) |
|
|
– |
|
Derivatives |
|
|
(127 |
) |
|
|
(111 |
) |
Real estate additions |
|
|
(1 |
) |
|
|
(19 |
) |
Purchase of property and equipment |
|
|
(9 |
) |
|
|
(24 |
) |
Net cash used in investing activities |
|
|
(2,692 |
) |
|
|
(403 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Policyholder account balances: |
|
|
|
|
|
|
|
|
Deposits |
|
|
3,321 |
|
|
|
4,459 |
|
Withdrawals |
|
|
(1,707 |
) |
|
|
(2,417 |
) |
Net proceeds received from issuance of shares of common stock |
|
|
1 |
|
|
|
– |
|
Net cash provided by financing activities |
|
|
1,615 |
|
|
|
2,042 |
|
Net decrease in cash |
|
|
(3,410 |
) |
|
|
(286 |
) |
Cash, beginning of period |
|
|
33,252 |
|
|
|
4,085 |
|
Cash, end of period |
|
$ |
29,842 |
|
|
$ |
3,799 |
|
Supplemental disclosures of cash flow information |
|
|
|
|
|
|
|
|
Supplemental non-cash activity: |
|
|
|
|
|
|
|
|
Deferral of sales inducements |
|
$ |
76 |
|
|
$ |
99 |
|
See accompanying notes to unaudited consolidated financial statements
4
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2019
(Unaudited)
Federal Life Group, Inc. (“FLG”, “we”, “us”, “our” or the “Company”) is a Pennsylvania corporation organized to be the stock holding company for Federal Life Mutual Holding Company and its subsidiaries (the “Predecessor”) following the 2018 conversion of Federal Life Mutual Holding Company from mutual to stock form (the “Conversion”). Federal Life Mutual Holding Company was subsequently renamed Federal Life Holding Company after the Conversion. Prior to the Conversion, FLG was not engaged in any significant operations and did not have any assets or liabilities. After the Conversion, which was completed on December 11, 2018, when FLG issued 3,530,150 shares at $10.00 per share for gross proceeds of $35.3 million, FLG’s primary assets are the outstanding capital stock of the Predecessor and a portion of the net proceeds of the Company’s initial public offering (“IPO”), which was completed on December 11, 2018. Prior to the Conversion, FLG was a direct, wholly-owned subsidiary of the Predecessor. Following the Conversion, the Company reorganized its corporate structure so that the Predecessor is a direct, wholly owned subsidiary of FLG. FLG now contains the accounts of its Predecessor and those accounts are now consolidated with those of FLG within the accompanying financial statements. The reorganization is considered a transaction between entities that are under common control. As a result, the consolidated financial statements prior to the IPO and the reorganization have been presented at their historical amounts.
The accompanying consolidated financial statements include the accounts of FLG and its subsidiaries, Federal Life Holding Company; FEDHO Holding Company (“FEDHO”); Federal Life Insurance Company (“Federal Life”); FED Mutual Financial Services, Inc. (“FED Mutual”); and Americana Realty Company (“Americana”). Additionally, the IPO described above resulted in a change in control according to Business Combinations (Topic 805), however, the Company elected not to apply push down accounting. Accordingly, the consolidated financial statements are presented at the Company’s historical carrying amounts. All intercompany transactions and balances have been eliminated in consolidation.
Federal Life, a subsidiary of Federal Life Holding Company, completed a reorganization in 2016 in which it converted from a mutual to a stock insurance company within a newly created mutual holding company structure. As part of this reorganization, Federal Life Mutual Holding Company was formed as an Illinois mutual insurance holding company and Federal Life continued its existence as an Illinois stock life insurance company. All of the shares of Federal Life were issued to FEDHO, an intermediate holding company that, in turn, is a wholly-owned subsidiary of the Federal Life Holding Company. Federal Life has two wholly-owned non-insurance subsidiaries, Americana and FED Mutual, discussed further below.
Federal Life’s in force business is primarily comprised of traditional life policies (term insurance, whole life insurance, non-medical health insurance, and group life insurance), interest sensitive contracts, and fixed deferred annuity contracts. Federal Life primarily sells its interest sensitive life, whole life, term life, fixed and indexed annuities through a network of independent agents. Federal Life is licensed to sell new business in the District of Columbia and all states except Maine, Massachusetts, New Hampshire, New York and Vermont. Although Federal Life is licensed to sell products in 45 states, its primary markets are Illinois, Michigan, Ohio, California, Florida, Texas, and Wisconsin.
Americana owns mineral rights in Arkansas, Georgia, Oklahoma and Texas. Americana earns royalty revenues from energy producers that are under agreement to drill for and produce oil and gas products on properties where Americana owns mineral rights.
FED Mutual is a FINRA licensed broker/dealer that was established to distribute Federal Life’s variable annuity products.
The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions for Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and notes required by GAAP for complete financial statements. The consolidated financial statements reflect all adjustments, consisting only of normal recurring items, which are necessary to present fairly our financial position and results of operations on a basis consistent with the prior audited consolidated financial statements. Operating results for the three month period ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019. The December 31, 2018 consolidated balance sheet data was derived from audited consolidated financial statements for the year ended December 31, 2018, which include all disclosures required by GAAP.
5
For further information related to a description of areas of judgement and estimates and other information necessary to understand our financial position and results of operations, refer to the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 10-K”).
Investor Information
Investor related information, including periodic reports filed on Forms 10-K, 10-Q and 8-K and any amendments may be found on our website at ir.federallife.com as soon as reasonably practicable after such reports are filed with the SEC. In addition, we have available on our website our: (i) compliance reporting policy; (ii) code of ethics; (iii) audit committee charter; (iv) compensation committee charter and (v) nominating committee charter. The information incorporated herein by reference is also electronically accessible from the SEC's website at www.sec.gov.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements. The most significant estimates include those used in determining the capitalization and amortization of deferred policy acquisition costs (“DAC”), the valuation of investments, future policy benefits (traditional life contracts, immediate annuities, supplemental contracts with life contingencies, and accident and health), the fair value of stock-based compensation awards, and the provision for income taxes. Actual results could differ from those estimates.
Emerging Growth Company
The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “Jobs Act”). As an emerging growth company, the Company utilizes the extended transition period provided in the Securities Act of 1933 for complying with new or revised accounting standards. Under this accommodation, the Company may early adopt a new or revised accounting standard only if early adoption is permitted by the standard. Changes in accounting principles issued but not yet adopted described below reflect the Company’s status as an Emerging Growth Company and the extended adoption period allowed for such companies.
Smaller Reporting Company
Additionally, the Company qualifies as a “smaller reporting company” as defined by Item 10(f)(1) of Regulation S-K. In some instances, this permits the Company to provide scaled disclosures under Regulation S-K and Regulation S-X.
Investments
Realized capital gains and losses on sales of investments include fixed maturity securities with calls and prepayments and are determined on the basis of specific security identification.
Equity securities are carried at fair value. Beginning with the adoption of Accounting Standards Update (“ASU”) No. 2016-01 on January 1, 2019, changes in the fair value of equity securities are recognized through net income. Prior to January 1, 2019, unrealized gains or losses were recorded in accumulated other comprehensive income (loss) (“AOCI”). Additionally, in connection with the adoption of ASU No. 2016-01, effective January 1, 2019, the Company has reclassified its investment in Federal Home Loan Bank (“FHLB”) common stock from equity securities to other invested assets. These investments are carried at redemption value. The carrying value of these investments at December 31, 2018 was $10,000.
Adopted Accounting Pronouncements
In March 2016, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2016-09, “Compensation - Stock Compensation”: Improvements to Employee Shared-Based Payment Accounting. The aspects of accounting guidance affected by this ASU are income taxes, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU was effective for annual reporting periods beginning after December 15, 2017. The Company adopted this ASU in the fourth quarter of fiscal 2018 upon the issuance of restricted stock and stock options to our employees. The adoption of the ASU did not have an impact on our financial statements as we did not previously have stock compensation. The Company has elected to account for forfeitures when they occur.
6
In February 2018, the FASB issued ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,” which provides an option to reclassify stranded tax effects within AOCI to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate described in the “Income Tax Reform” section below is recorded. ASU No. 2018-02 is effective for fiscal years beginning after December 15, 2018 and should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the Tax Act is recognized. The Company early adopted ASU No. 2018-02 effective December 31, 2017 using the portfolio method, which resulted in the reclassification of $805,000 of stranded tax effects from AOCI to retained earnings within the Company’s consolidated financial statements.
In May 2014, the FASB issued an ASU 2014-09 “Revenue from Contracts with Customers,” related to revenue arising from contracts with customers. This ASU, which replaces most current revenue recognition guidance, including industry specific guidance, prescribes that an entity should recognize revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We adopted this ASU on January 1, 2019. The adoption of this ASU had no impact on our consolidated financial statements as revenues related to insurance contracts and investment contracts are excluded from its scope.
In January 2016, the FASB issued ASU No. 2016-01 “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities,” which revises an entity’s accounting related to the classification and measurement of certain equity investments and the presentation of certain fair value changes for financial liabilities measured at fair value. The guidance also amends certain disclosure requirements associated with the fair value of financial instruments. ASU No. 2016-01 is effective for non-public companies for annual periods beginning after December 15, 2018. We adopted this guidance effective January 1, 2019 with no material impact to our consolidated financial statements. Changes in fair value of equity securities, previously recognized through other comprehensive income (loss), are now recognized in net investment gains. We also recorded a cumulative effect adjustment to increase retained earnings by $1,160,000, net of tax, as of January 1, 2019 for unrealized gains previously recognized in AOCI. For additional information, please see Note 7.
Issued Accounting Pronouncements Not Yet Adopted
In February 2016, the FASB issued ASU No. 2016-02 “Leases”, that will require recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements, This ASU affects accounting and disclosure more dramatically for lessees as accounting for lessors is mainly unchanged. This ASU is effective January 1, 2020. At this time, we do not believe the adoption of ASU No. 2016-02 will have an impact on the Company’s consolidated financial statements, as we do not have any material leases.
In August 2018, the FASB issued ASU No. 2018-12, “Targeted Improvements to the Accounting for Long-Duration Contracts,” which revises certain aspects of the measurement models and disclosure requirements for long duration insurance and investment contracts. The FASB’s objective in issuing this ASU is to improve, simplify, and enhance the accounting for long-duration contracts. The revisions include updating cash flow assumptions in the calculation of the liability for traditional life products, introducing the term ‘market risk benefit’ (“MRB”) and requiring all contract features meeting the definition of an MRB to be measured at fair value, simplifying the method used to amortize DAC and deferred sales inducement costs (“DSIC”) to a constant basis over the expected term of the related contracts rather than based on gross profits and enhancing disclosure requirements. ASU is effective on January 1, 2022, the transition date (the remeasurement date) is January 1, 2020. Early adoption of this ASU is permitted. The Company is currently assessing the impact of the guidance on its consolidated financial statements.
In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging – Targeted Improvements to Accounting for Hedging Activities,” which changes the recognition and presentation requirements of hedge accounting. ASU No. 2017-12 is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The adoption of ASU No. 2017- 12 is not expected to have a material impact on the Company’s consolidated financial statements.
In March 2017, the FASB issued ASU No. 2017-08, “Receivables – Nonrefundable Fees and Other Costs: Premium Amortization of Purchased Callable Debt Securities,” which requires that certain premiums on callable debt securities be amortized to the earliest call date. ASU No. 2017-08 is effective for annual periods beginning after December 15, 2019. Early adoption is permitted. The adoption of ASU No. 2017-08 is not expected to have a material impact on the Company’s consolidated financial statements.
7
In June 2016, the FASB issued ASU No. 2016-13 “Financial Instruments – Credit Losses: Measurement of Credit Losses of Financial Instruments,” which provides a new current expected credit loss model to account for credit losses on certain financial assets and off-balance sheet exposure. The model requires an entity to estimate lifetime credit losses related to such assets and exposure based on relevant information about past events, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The guidance also modifies the current other-than- temporary impairment guidance for available-for-sale debt securities to require the use of an allowance rather than a direct write down of the investment and replaces existing guidance for purchased credit deteriorated loans and debt securities. ASU No. 2016-13 is effective for annual reporting periods beginning after December 15, 2020 with early adoption permitted for annual periods beginning after December 15, 2018. The Company is currently assessing the impact of the guidance on its consolidated financial statements.
4.Investments and Related Income
The Company’s principal investments are in fixed income securities, equity securities, and policy loans.
The following table presents the amortized cost, gross unrealized gains (losses) and fair value of the Company’s fixed maturity securities as of March 31, 2019 and December 31, 2018. Equity securities were removed from this table upon adoption of ASU No. 2016-01 at January 1, 2019.
|
|
March 31, 2019 |
|
|||||||||||||
|
|
Amortized |
|
|
Gross Unrealized |
|
|
Fair |
|
|||||||
|
|
Cost |
|
|
Gains |
|
|
Losses |
|
|
Value |
|
||||
|
|
(Dollars in thousands) |
|
|||||||||||||
U.S. government |
|
$ |
4,060 |
|
|
$ |
136 |
|
|
$ |
(92 |
) |
|
$ |
4,104 |
|
States, political subdivisions, other |
|
|
33,699 |
|
|
|
778 |
|
|
|
(90 |
) |
|
|
34,387 |
|
Corporate |
|
|
109,523 |
|
|
|
2,211 |
|
|
|
(749 |
) |
|
|
110,985 |
|
Residential mortgage-backed securities |
|
|
39,703 |
|
|
|
990 |
|
|
|
(92 |
) |
|
|
40,601 |
|
Commercial mortgage-backed securities |
|
|
5,588 |
|
|
|
137 |
|
|
|
(49 |
) |
|
|
5,676 |
|
Total fixed maturity securities |
|
$ |
192,573 |
|
|
$ |
4,252 |
|
|
$ |
(1,072 |
) |
|
$ |
195,753 |
|
|
|
December 31, 2018 |
|
|||||||||||||
|
|
Amortized |
|
|
Gross Unrealized |
|
|
Fair |
|
|||||||
|
|
Cost |
|
|
Gains |
|
|
Losses |
|
|
Value |
|
||||
|
|
(Dollars in thousands) |
|
|||||||||||||
U.S. government |
|
$ |
4,063 |
|
|
$ |
142 |
|
|
$ |
(148 |
) |
|
$ |
4,057 |
|
States, political subdivisions, other |
|
|
30,881 |
|
|
|
472 |
|
|
|
(364 |
) |
|
|
30,989 |
|
Corporate |
|
|
108,664 |
|
|
|
617 |
|
|
|
(2,995 |
) |
|
|
106,286 |
|
Residential mortgage-backed securities |
|
|
37,755 |
|
|
|
455 |
|
|
|
(688 |
) |
|
|
37,522 |
|
Commercial mortgage-backed securities |
|
|
5,672 |
|
|
|
73 |
|
|
|
(124 |
) |
|
|
5,621 |
|
Total fixed maturity securities |
|
|
187,035 |
|
|
|
1,759 |
|
|
|
(4,319 |
) |
|
|
184,475 |
|
Equity securities |
|
|
4,514 |
|
|
|
1,528 |
|
|
|
(38 |
) |
|
|
6,004 |
|
Total fixed maturity and equity securities |
|
$ |
191,549 |
|
|
$ |
3,287 |
|
|
$ |
(4,357 |
) |
|
$ |
190,479 |
|
The scheduled maturities for fixed income securities as of March 31, 2019 and December 31, 2018 are as follows:
|
|
March 31, 2019 |
|
|
December 31, 2018 |
|
||||||||||
|
|
Amortized |
|
|
Fair |
|
|
Amortized |
|
|
Fair |
|
||||
|
|
Cost |
|
|
Value |
|
|
Cost |
|
|
Value |
|
||||
|
|
(Dollars in thousands) |
|
|||||||||||||
Due in one year or less |
|
$ |
6,699 |
|
|
$ |
6,795 |
|
|
$ |
5,998 |
|
|
$ |
6,041 |
|
Due after one year through five years |
|
|
34,683 |
|
|
|
35,506 |
|
|
|
37,917 |
|
|
|
38,032 |
|
Due after five years through ten years |
|
|
77,014 |
|
|
|
77,945 |
|
|
|
74,274 |
|
|
|
72,209 |
|
Due after ten years |
|
|
28,886 |
|
|
|
29,230 |
|
|
|
25,419 |
|
|
|
25,050 |
|
Mortgage-backed securities |
|
|
45,291 |
|
|
|
46,277 |
|
|
|
43,427 |
|
|
|
43,143 |
|
Total |
|
$ |
192,573 |
|
|
$ |
195,753 |
|
|
$ |
187,035 |
|
|
$ |
184,475 |
|
Actual maturities may differ from those scheduled as a result of prepayments by the issuers. Because of the potential for prepayment on mortgage-backed securities, they are not categorized by contractual maturity.
8
The following table presents the sources of investment proceeds and the related gross realized investment gains (losses) for the three month periods ended March 31, 2019 and March 31, 2018, respectively:
|
|
Three Months Ended |
|
|||||||||
|
|
March 31, 2019 |
|
|||||||||
|
|
Fixed |
|
|
Equity |
|
|
Derivative |
|
|||
|
|
Maturities |
|
|
Securities |
|
|
Instruments |
|
|||
|
|
(Dollars in thousands) |
|
|||||||||
Proceeds from sales or maturities |
|
$ |
3,768 |
|
|
$ |
2,827 |
|
|
$ |
77 |
|
Gross gains from sales or maturities |
|
|
11 |
|
|
|
715 |
|
|
|
107 |
|
Gross losses from sales or maturities |
|
|
(2 |
) |
|
|
(12 |
) |
|
|
(140 |
) |
|
|
Three Months Ended |
|
|||||||||
|
|
March 31, 2018 |
|
|||||||||
|
|
Fixed |
|
|
Equity |
|
|
Derivative |
|
|||
|
|
Maturities |
|
|
Securities |
|
|
Instruments |
|
|||
|
|
(Dollars in thousands) |
|
|||||||||
Proceeds from sales or maturities |
|
$ |
5,614 |
|
|
$ |
– |
|
|
$ |
128 |
|
Gross gains from sales or maturities |
|
|
48 |
|
|
|
– |
|
|
|
226 |
|
Gross losses from sales or maturities |
|
|
(33 |
) |
|
|
– |
|
|
|
(151 |
) |
For the three month period ended March 31, 2019, the Company also recognized $105,000 of unrealized losses on equity securities in net investment gains in accordance with the adoption of ASU 2016-01.
For the three month periods ended March 31, 2019 and March 31, 2018 the Company did not recognize any impairment losses.
The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income and equity security whose carrying value may be other-than-temporarily impaired.
For each fixed income security in an unrealized loss position, the Company assesses whether management with the appropriate authority has made a decision to sell or whether it is probable that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If a security meets any of these criteria, the security’s decline in fair value is deemed other than temporary and is recorded in earnings.
If the Company has not made the decision to sell the fixed income security and it is not more likely than not that the Company will be required to sell the fixed income security before recovery of its amortized cost basis, the Company evaluates if it expects to receive cash flows sufficient to recover the entire amortized cost basis of the security by comparing the estimated recovery value calculated by discounting the best estimate of future cash flows at the security’s original or current effective rate, as appropriate, with the amortized cost of the security. If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in earnings, with the remaining amount of the unrealized loss deemed to be related to other factors and recognized in AOCI.
The Company’s portfolio monitoring process includes a quarterly review of all securities through a screening process which identifies instances where the fair value compared to amortized cost for fixed income securities and cost for equity securities is below established thresholds, and also includes the monitoring of other criteria such as ratings, ratings downgrades or payment defaults. The securities identified, in addition to other securities for which the Company may have a concern, are evaluated for potential other-than-temporary impairment using all reasonably available information relevant to the collectability or recovery of the security. Inherent in the Company’s evaluation of other-than-temporary impairment for these fixed income and equity securities are assumptions and estimates about the financial condition of the issue or issuer and its future earnings potential. Some of the factors considered in evaluating whether a decline in fair value is other than temporary are: 1) the length of time and extent to which the fair value has been less than amortized cost for fixed income securities, or cost for equity securities; 2) the financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry specific market conditions and trends, geographic location and implications of rating agency actions and offering prices; and 3) the specific reasons that a security is in a significant unrealized loss position, including overall market conditions which could affect liquidity.
9
The following table shows the fair value and gross unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at March 31, 2019 and December 31, 2018. Equity securities were removed from this table upon adoption of ASU No. 2016-01 at January 1, 2019.
March 31, 2019 |
|
Less than 12 months |
|
|
12 months or longer |
|
|
Total |
|
|||||||||||||||
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|||
|
|
Fair |
|
|
Unrealized |
|
|
Fair |
|
|
Unrealized |
|
|
Fair |
|
|
Unrealized |
|
||||||
Description of securities |
|
Value |
|
|
Loss |
|
|
Value |
|
|
Loss |
|
|
Value |
|
|
Loss |
|
||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||
U.S. government |
|
$ |
– |
|
|
$ |
– |
|
|
$ |
2,960 |
|
|
$ |
(92 |
) |
|
$ |
2,960 |
|
|
$ |
(92 |
) |
States, political subdivisions, other |
|
|
3,045 |
|
|
|
(8 |
) |
|
|
5,619 |
|
|
|
(82 |
) |
|
|
8,664 |
|
|
|
(90 |
) |
Corporate |
|
|
4,990 |
|
|
|
(46 |
) |
|
|
25,724 |
|
|
|
(703 |
) |
|
|
30,714 |
|
|
|
(749 |
) |
Residential mortgage-backed securities |
|
|
– |
|
|
|
– |
|
|
|
10,164 |
|
|
|
(92 |
) |
|
|
10,164 |
|
|
|
(92 |
) |
Commercial mortgage-backed securities |
|
|
50 |
|
|
|
(2 |
) |
|
|
2,474 |
|
|
|
(47 |
) |
|
|
2,524 |
|
|
|
(49 |
) |
Total |
|
$ |
8,085 |
|
|
$ |
(56 |
) |
|
$ |
46,941 |
|
|
$ |
(1,016 |
) |
|
$ |
55,026 |
|
|
$ |
(1,072 |
) |
December 31, 2018 |
|
Less than 12 months |
|
|
12 months or longer |
|
|
Total |
|
|||||||||||||||
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|||
|
|
Fair |
|
|
Unrealized |
|
|
Fair |
|
|
Unrealized |
|
|
Fair |
|
|
Unrealized |
|
||||||
Description of securities |
|
Value |
|
|
Loss |
|
|
Value |
|
|
Loss |
|
|
Value |
|
|
Loss |
|
||||||
|
|
(Dollars in thousands) |
|
|||||||||||||||||||||
U.S. government |
|
$ |
– |
|
|
$ |
– |
|
|
$ |
2,907 |
|
|
$ |
(148 |
) |
|
$ |
2,907 |
|
|
$ |
(148 |
) |
States, political subdivisions, other |
|
|
6,106 |
|
|
|
(103 |
) |
|
|
9,339 |
|
|
|
(261 |
) |
|
|
15,445 |
|
|
|
(364 |
) |
Corporate |
|
|
49,193 |
|
|
|
(1,886 |
) |
|
|